FDA Panel to Review Psychedelic Drug MDMA for First Time

By Sriparna Roy and Pratik Jain(Reuters) - A panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a therapy...

By Sriparna Roy and Pratik Jain(Reuters) - A panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a therapy...